标题
Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer
作者
关键词
-
出版物
JOURNAL OF SURGICAL ONCOLOGY
Volume 107, Issue 1, Pages 15-22
出版商
Wiley
发表日期
2012-06-22
DOI
10.1002/jso.23192
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The prognostic and predictive value of serum CA19.9 in pancreatic cancer
- (2012) J. L. Humphris et al. ANNALS OF ONCOLOGY
- Integrative Survival-Based Molecular Profiling of Human Pancreatic Cancer
- (2012) Timothy R. Donahue et al. CLINICAL CANCER RESEARCH
- Correction: A Novel Survival-Based Tissue Microarray of Pancreatic Cancer Validates MUC1 and Mesothelin as Biomarkers
- (2012) Jordan M. Winter et al. PLoS One
- Pancreatic Cancer Surgery in the New Millennium
- (2011) Werner Hartwig et al. ANNALS OF SURGERY
- Survival after Resection of Pancreatic Adenocarcinoma: Results from a Single Institution over Three Decades
- (2011) Jordan M. Winter et al. ANNALS OF SURGICAL ONCOLOGY
- Metabolomic Profiling of Serum from Human Pancreatic Cancer Patients Using 1H NMR Spectroscopy and Principal Component Analysis
- (2011) Dong OuYang et al. APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
- Feasibility of Identifying Pancreatic Cancer Based on Serum Metabolomics
- (2011) O. F. Bathe et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Serum Biomarker Panels for the Detection of Pancreatic Cancer
- (2011) R. E. Brand et al. CLINICAL CANCER RESEARCH
- The Clinical Utility and Limitations of Serum Carbohydrate Antigen (CA19-9) as a Diagnostic Tool for Pancreatic Cancer and Cholangiocarcinoma
- (2011) Sundeep Singh et al. DIGESTIVE DISEASES AND SCIENCES
- Validation Study of a Quantitative Multigene Reverse Transcriptase–Polymerase Chain Reaction Assay for Assessment of Recurrence Risk in Patients With Stage II Colon Cancer
- (2011) Richard G. Gray et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Cetuximab, Gemcitabine, and Oxaliplatin Followed by Chemoradiation With Cetuximab for Locally Advanced (T4) Pancreatic Adenocarcinoma: Correlation ofSmad4(Dpc4)Immunostaining With Pattern of Disease Progression
- (2011) Christopher H. Crane et al. JOURNAL OF CLINICAL ONCOLOGY
- Four-Year Follow-Up of Trastuzumab Plus Adjuvant Chemotherapy for Operable Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Joint Analysis of Data From NCCTG N9831 and NSABP B-31
- (2011) Edith A. Perez et al. JOURNAL OF CLINICAL ONCOLOGY
- Urine Metabolic Signature of Pancreatic Ductal Adenocarcinoma by 1H Nuclear Magnetic Resonance: Identification, Mapping, and Evolution
- (2011) Claudia Napoli et al. JOURNAL OF PROTEOME RESEARCH
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- An Emerging Entity: Pancreatic Adenocarcinoma Associated with a Known BRCA Mutation: Clinical Descriptors, Treatment Implications, and Future Directions
- (2011) M. A. Lowery et al. ONCOLOGIST
- K-ras Mutations in the Plasma Correspond to Computed Tomographic Findings in Patients With Pancreatic Cancer
- (2011) Jan Däbritz et al. PANCREAS
- Tissue and Serum microRNAs in the KrasG12D Transgenic Animal Model and in Patients with Pancreatic Cancer
- (2011) Joseph J. LaConti et al. PLoS One
- Prognostic Impact of Perioperative Serum CA 19-9 Levels in Patients with Resectable Pancreatic Cancer
- (2010) Naru Kondo et al. ANNALS OF SURGICAL ONCOLOGY
- CA19-9 as a predictor of tumor response and survival in patients with advanced pancreatic cancer treated with gemcitabine based chemotherapy
- (2010) Nazik HAMMAD et al. Asia-Pacific Journal of Clinical Oncology
- Identification of novel pancreatic adenocarcinoma cell-surface targets by gene expression profiling and tissue microarray
- (2010) David L. Morse et al. BIOCHEMICAL PHARMACOLOGY
- Proteomics analysis of serum protein profiling in pancreatic cancer patients by DIGE: up-regulation of mannose-binding lectin 2 and myosin light chain kinase 2
- (2010) Yefei Rong et al. BMC GASTROENTEROLOGY
- Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis
- (2010) A Xue et al. BRITISH JOURNAL OF CANCER
- A phase 2 trial of gemcitabine, 5-fluorouracil, and radiation therapy in locally advanced nonmetastatic pancreatic adenocarcinoma
- (2010) Harvey J. Mamon et al. CANCER
- Sensitive and quantitative detection of KRAS2 gene mutations in pancreatic duct juice differentiates patients with pancreatic cancer from chronic pancreatitis, potential for early detection
- (2010) Chanjuan Shi et al. CANCER BIOLOGY & THERAPY
- Pilot Study Using Molecular Profiling of Patients' Tumors to Find Potential Targets and Select Treatments for Their Refractory Cancers
- (2010) Daniel D. Von Hoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Personalizing Cancer Treatment in the Age of Global Genomic Analyses: PALB2 Gene Mutations and the Response to DNA Damaging Agents in Pancreatic Cancer
- (2010) M. C. Villarroel et al. MOLECULAR CANCER THERAPEUTICS
- A Six-Gene Signature Predicts Survival of Patients with Localized Pancreatic Ductal Adenocarcinoma
- (2010) Jeran K. Stratford et al. PLOS MEDICINE
- Results of a Phase I Trial of 12 Patients With Locally Advanced Pancreatic Carcinoma Combining Gefitinib, Paclitaxel, and 3-Dimensional Conformal Radiation
- (2009) Christine C. Olsen et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- CA19-9 serum levels in obstructive jaundice: clinical value in benign and malignant conditions
- (2009) Daniele Marrelli et al. AMERICAN JOURNAL OF SURGERY
- MicroRNAs in Plasma of Pancreatic Ductal Adenocarcinoma Patients as Novel Blood-Based Biomarkers of Disease
- (2009) J. Wang et al. Cancer Prevention Research
- The Role of HuR in Gemcitabine Efficacy in Pancreatic Cancer: HuR Up-regulates the Expression of the Gemcitabine Metabolizing Enzyme Deoxycytidine Kinase
- (2009) C. L. Costantino et al. CANCER RESEARCH
- Identification of serum biomarkers for pancreatic adenocarcinoma by proteomic analysis
- (2009) Jinghui Guo et al. CANCER SCIENCE
- The identification of phosphoglycerate kinase-1 and histone H4 autoantibodies in pancreatic cancer patient serum using a natural protein microarray
- (2009) Tasneem H. Patwa et al. ELECTROPHORESIS
- Association of GUCY2C Expression in Lymph Nodes With Time to Recurrence and Disease-Free Survival in pN0 Colorectal Cancer
- (2009) Scott A. Waldman JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- DPC4 Gene Status of the Primary Carcinoma Correlates With Patterns of Failure in Patients With Pancreatic Cancer
- (2009) Christine A. Iacobuzio-Donahue et al. JOURNAL OF CLINICAL ONCOLOGY
- Very High Serum CA 19-9 Levels: A Contraindication to Pancreaticoduodenectomy?
- (2009) O. Turrini et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Predictive and Prognostic Value of CA 19-9 in Resected Pancreatic Adenocarcinoma
- (2009) Joshua G. Barton et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers
- (2009) Peter C. Fong et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
- (2009) Eric Van Cutsem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene
- (2009) S. Jones et al. SCIENCE
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- A Compendium of Potential Biomarkers of Pancreatic Cancer
- (2009) H. C. Harsha et al. PLOS MEDICINE
- The Impact of Resection Margin Status and Postoperative CA19-9 Levels on Survival and Patterns of Recurrence After Postoperative High-Dose Radiotherapy With 5-FU—Based Concurrent Chemotherapy for Resectable Pancreatic Cancer
- (2008) Timothy J. Kinsella et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Preoperative CA 19-9 and the Yield of Staging Laparoscopy in Patients with Radiographically Resectable Pancreatic Adenocarcinoma
- (2008) Shishir K. Maithel et al. ANNALS OF SURGICAL ONCOLOGY
- Adenoviral-mediated overexpression of human equilibrative nucleoside transporter 1 (hENT1) enhances gemcitabine response in human pancreatic cancer
- (2008) Sandra Pérez-Torras et al. BIOCHEMICAL PHARMACOLOGY
- The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status
- (2008) Rodrigo Jover et al. EUROPEAN JOURNAL OF CANCER
- Gene Panel Model Predictive of Outcome in Men at High-Risk of Systemic Progression and Death From Prostate Cancer After Radical Retropubic Prostatectomy
- (2008) John C. Cheville et al. JOURNAL OF CLINICAL ONCOLOGY
- Postresection CA 19-9 Predicts Overall Survival in Patients With Pancreatic Cancer Treated With Adjuvant Chemoradiation: A Prospective Validation by RTOG 9704
- (2008) Adam C. Berger et al. JOURNAL OF CLINICAL ONCOLOGY
- Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study
- (2008) Kerby Shedden et al. NATURE MEDICINE
- Serum CA19-9 Decline Compared to Radiographic Response as a Surrogate for Clinical Outcomes in Patients With Metastatic Pancreatic Cancer Receiving Chemotherapy
- (2008) Derrick Wong et al. PANCREAS
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
- (2008) S. Jones et al. SCIENCE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started